Invention Grant
- Patent Title: Adenovirus vaccine vectors
-
Application No.: US13643788Application Date: 2011-04-28
-
Publication No.: US09862931B2Publication Date: 2018-01-09
- Inventor: Karim Benihoud , Anastasia Lanzi , Michel Perricaudet
- Applicant: Karim Benihoud , Anastasia Lanzi , Michel Perricaudet
- Applicant Address: FR Villejuif
- Assignee: Institut Gustave Roussy
- Current Assignee: Institut Gustave Roussy
- Current Assignee Address: FR Villejuif
- Agency: Morgan, Lewis & Bockius LLP
- Priority: EP10290223 20100428; EP10290390 20100713
- International Application: PCT/IB2011/051878 WO 20110428
- International Announcement: WO2012/150478 WO 20121108
- Main IPC: C12N7/00
- IPC: C12N7/00 ; C07K14/005 ; A61K39/235 ; A61K39/00 ; C12N15/86
Abstract:
The invention relates to recombinant adenovirus displaying one or more heterologous epitope(s) on their fiber protein. These recombinant adenovirus are useful as vaccines for generating an immune response against said epitope(s) in individuals having a pre-existing anti-Ad immunity.
Public/Granted literature
- US20130164327A1 Adenovirus vaccine vectors Public/Granted day:2013-06-27
Information query
